Adriamycin alopecia prevented by cold air scalp cooling.
Preliminary studies are reported on the effectiveness of cold air scalp cooling to prevent alopecia in patients receiving Adriamycin. Cold air produced in a novel way using a vortex refrigeration tube was applied to the scalp for 15 min before and 30 min after the administration of Adriamycin and other cytotoxic agents. Sixteen of 26 patients had no hair loss, four had slight hair loss, and six required a wig. Two subgroups fared particularly well. Four of four patients treated with ABVD for Hodgkin's disease and nine of 13 treated with Adriamycin (40 mg/m2) and vincristine (2 mg) for breast cancer had no hair loss.
D000392:Air Movements; D000505:Alopecia / Q000139:chemically induced / Q000517:prevention & control*; D004317:Doxorubicin / Q000009:adverse effects*; D006801:Humans; D007036:Hypothermia, Induced
D004317:Doxorubicin